8-K Announcements
6May 7, 2026·SEC
May 7, 2026·SEC
Apr 17, 2026·SEC
Cross Country Healthcare, Inc. (CCRN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company's minimal debt-to-equity ratio of 0.01 provides a safety net, the lack of bottom-line profitability and a -0.8% operating margin suggest that a clear path to earnings growth has yet to materialize.
Cross Country Healthcare, Inc. (CCRN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Cross Country Healthcare, Inc. (CCRN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.03vs $0.05+40.0% | $241Mvs $237M+1.7% |
| Q2 2026 | Mar 4, 2026 | $0.06vs $0.03-300.0% | $237Mvs $254M-6.9% |
| Q4 2025 | Nov 12, 2025 | $0.03vs $0.04-25.0% | $250Mvs $254M-1.7% |
| Q3 2025 | Aug 6, 2025 | $0.01vs $0.07-114.3% | $274Mvs $294M-6.7% |
Key metrics vs top competitors for Cross Country Healthcare, Inc. (CCRN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $13.22 | $427.44M | -4.51 | -21.56% | -9% | -25.57% | — | |
| $33.25 | $1.29B | -13.41 | -8.49% | -0.95% | -4.98% | — | |
| $7.22 | $219.2M | -4.48 | 3.1% | -4.29% | -18.74% | — | |
| $24.39 | $1.67B | 30.11 | 7.08% | 3.67% | 13.6% | — | |
| $13.51 | $468.38M | -1.87 | -1.87% | -6.44% | -24.58% | — | |
| $39.34 | $1.83B | -135.66 | 0.58% | -0.09% | -0.81% | — |
Cross Country Healthcare, Inc. (CCRN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Cross Country Healthcare, Inc. (CCRN) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
May 7, 2026·SEC
Apr 17, 2026·SEC
Get notified when CCRN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Cross Country Healthcare, Inc. (CCRN) stock FAQ — growth, dividends, profitability & financials explained
Cross Country Healthcare, Inc. (CCRN) reported $1.00B in revenue for fiscal year 2025. This represents a 417% increase from $193.8M in 1999.
Cross Country Healthcare, Inc. (CCRN) saw revenue decline by 21.6% over the past year.
Cross Country Healthcare, Inc. (CCRN) reported a net loss of $98.6M for fiscal year 2025.
Cross Country Healthcare, Inc. (CCRN) has a return on equity (ROE) of -25.6%. Negative ROE indicates the company is unprofitable.
Cross Country Healthcare, Inc. (CCRN) generated $39.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.